Clinical Trial Update: Effect of High Dose Vitamin D Supplementation on HIV Latency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose vitamin D supplementation effects on HIV latency; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: University of Melbourne | Conditions: Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED